Matrikines and the lungs

被引:33
作者
Burgess, Janette K. [1 ,2 ,3 ]
Weckmann, Markus [4 ]
机构
[1] Woolcock Inst Med Res, Sydney, NSW 2050, Australia
[2] Univ Sydney, Discipline Pharmacol, Sydney, NSW 2006, Australia
[3] Cooperat Res Ctr Asthma & Airways, Sydney, NSW, Australia
[4] Univ Med Ctr Schleswig Holstein, Lubeck, Germany
基金
澳大利亚国家健康与医学研究理事会;
关键词
Airway remodelling; Extracellular matrix; Matrikines; Fibronectin; Collagen; Proteases; HEPARAN-SULFATE PROTEOGLYCAN; EXTRACELLULAR-MATRIX PROTEIN; EPIDERMAL-GROWTH-FACTOR; AMYLOID PRECURSOR PROTEIN; DENSITY-LIPOPROTEIN-RECEPTOR; ELASTIN-DERIVED PEPTIDES; MEDIATED CELL-ADHESION; PRE-MESSENGER-RNA; FIBRONECTIN ISOFORM DISTRIBUTION; OBSTRUCTIVE PULMONARY-DISEASE;
D O I
10.1016/j.pharmthera.2012.02.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The extracellular matrix is a complex network of fibrous and nonfibrous molecules that not only provide structure to the lung but also interact with and regulate the behaviour of the cells which it surrounds. Recently it has been recognised that components of the extracellular matrix proteins are released, often through the action of endogenous proteases, and these fragments are termed matrikines. Matrikines have biological activities, independent of their role within the extracellular matrix structure, which may play important roles in the lung in health and disease pathology. Integrins are the primary cell surface receptors, characterised to date, which are used by the matrikines to exert their effects on cells. However, evidence is emerging for the need for co-factors and other receptors for the matrikines to exert their effects on cells. The potential for matrikines, and peptides derived from these extracellular matrix protein fragments, as therapeutic agents has recently been recognised. The natural role of these matrikines (including inhibitors of angiogenesis and possibly inflammation) make them ideal targets to mimic as therapies. A number of these peptides have been taken forward into clinical trials. The focus of this review will be to summarise our current understanding of the role, and potential for highly relevant actions, of matrikines in lung health and disease. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:317 / 337
页数:21
相关论文
共 396 条
[1]   Fragments of extracellular matrix as mediators of inflammation [J].
Adair-Kirk, Tracy L. ;
Senior, Robert M. .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2008, 40 (6-7) :1101-1110
[2]  
Aggeli AS, 2009, J NEPHROL, V22, P130
[3]   Extracellular matrix components and regulators in the airway smooth muscle in asthma [J].
Araujo, B. B. ;
Dolhnikoff, M. ;
Silva, L. F. F. ;
Elliot, J. ;
Lindeman, J. H. N. ;
Ferreira, D. S. ;
Mulder, A. ;
Gomes, H. A. P. ;
Fernezlian, S. M. ;
James, A. ;
Mauad, T. .
EUROPEAN RESPIRATORY JOURNAL, 2008, 32 (01) :61-69
[4]   Cyclin-dependent kinase inhibitors and JNK act as molecular switches, regulating the choice between growth arrest and apoptosis induced by galectin-8 [J].
Arbel-Goren, R ;
Levy, Y ;
Ronen, D ;
Zick, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (19) :19105-19114
[5]   Perlecan is essential for cartilage and cephalic development [J].
Arikawa-Hirasawa, E ;
Watanabe, H ;
Takami, H ;
Hassell, JR ;
Yamada, Y .
NATURE GENETICS, 1999, 23 (03) :354-358
[6]   Imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from asthmatic subjects [J].
Asai, K ;
Kanazawa, H ;
Otani, K ;
Shiraishi, S ;
Hirata, K ;
Yoshikawa, J .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 110 (04) :571-575
[7]   Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican [J].
Aspberg, A ;
Adam, S ;
Kostka, G ;
Timpl, R ;
Heinegård, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (29) :20444-20449
[8]   The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein-protein interactions independent of carbohydrate moiety [J].
Aspberg, A ;
Miura, R ;
Bourdoulous, S ;
Shimonaka, M ;
Heinegard, D ;
Schachner, M ;
Ruoslahti, E ;
Yamaguchi, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (19) :10116-10121
[9]   Fibronectins in vascular morphogenesis [J].
Astrof, Sophie ;
Hynes, Richard O. .
ANGIOGENESIS, 2009, 12 (02) :165-175
[10]  
AUKHIL I, 1993, J BIOL CHEM, V268, P2542